U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug development.
U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on theground-breaking discoveries made by its founder - Professor Axel Ullrich.Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 6, 2003 | Series Unknown | €14.35M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BioM Venture Capital | — | Series Unknown |